Acute oral toxicity test and assessment of rhynchophylline in mice

doi:10.5246/jcps.2021.08.053

Abstract

Abstract:

As the main alkaloid constituent of Uncaria species, rhynchophylline has drawn extensive attention in recent years for its antihypertensive and neuroprotective activities. However, toxicity study of the rhynchophylline is still lacking. In the present study, oral acute toxicity of rhynchophylline was conducted in Kunming mice. The mice were orally treated with 520.00, 442.00, 375.70, 319.34 and 271.44 mg/kg of rhynchophylline for 14 d. The general behavior, body weight changes, toxic reaction, and death were recorded, and histopathological analyses were performed. The acute toxicity was evaluated by the assessment of the median lethal dose (LD₅₀). The acute toxicity study showed that no significant difference was found in the body weight of the mice in the control group and those in the drug group. However, the mice treated with rhynchophylline showed obvious abnormal symptoms and mortality. The median lethal dose (LD₅₀) of orally administered rhynchophylline was 308.08 mg/kg. The histopathological results showed that the mice in the high-dose rhynchophylline group displayed toxic effects in the brain, liver, lung, and kidney. The results of the current study indicated that rhynchophylline could not be taken at a high dose. Collectively, our current findings provided a strong basis for further clinical investigation.

Key words: Rhynchophylline, Acute oral toxicity, Median lethal dose, Mice

Supporting:

Lanlan Hu, Huijing Zhang, Le Zhang, Jianlin Tang. Acute oral toxicity test and assessment of rhynchophylline in mice[J]. Journal of Chinese Pharmaceutical Sciences, 2021, 30(8): 657-665.

Figures/Tables 4

References 26

[1]	Barrett, B.; Kiefer, D.; Rabago, D. Assessing the risks and benefits of herbal medicine: an overview of scientific evidence. Altern. Ther. Health Med. 1999, 5, 40–49.
[2]	Bateman, J.; Chapman, R.D.; Simpson, D. Possible toxicity of herbal remedies. Scott. Med. J. 1998, 43, 7–15.
[3]	Kim, E.J.Y.; Chen, Y.L.; Huang, J.Q.; Li, K.M.; Razmovski-Naumovski, V.; Poon, J.; Chan, K.; Roufogalis, B.D.; McLachlan, A.J.; Mo, S.L.; Yang, D.P.; Yao, M.C.; Liu, Z.L.; Liu, J.P.; Li, G.Q. Evidence-based toxicity evaluation and scheduling of Chinese herbal medicines. J. Ethnopharmacol. 2013, 146, 40–61.
[4]	Pharmacopoeia of the Peoples Republic of China (2015). Vol 1 [S]. 2015, 257.
[5]	Xu, X.H.; Wu, H. A review of the genus Uncaria schreber of China. J. South China Agric. College. 1981, 2, 21–28.
[6]	Hsieh, C.L.; Chen, M.F.; Li, T.C.; Li, S.C.; Tang, N.Y.; Hsieh, C.T.; Pon, C.Z.; Lin, J.G. Anticonvulsant effect of Uncaria rhynchophylla (Miq) Jack. in rats with kainic acid-induced epileptic seizure. Am. J. Chin. Med. 1999, 27, 257–264.
[7]	Hsieh, C.L.; Tang, N.Y.; Chiang, S.Y.; Hsieh, C.T.; Lin, J.G. Anticonvulsive and free radical scavenging actions of two herbs, Uncaria rhynchophylla (Miq) jack and Gastrodia elata Bl., in kainic acid-treated rats. Life Sci. 1999, 65, 2071–2082.
[8]	Heitzman, M.E.; Neto, C.C.; Winiarz, E.; Vaisberg, A.J.; Hammond, G.B. Ethnobotany, phytochemistry and pharmacology of Uncaria (Rubiaceae). Phytochemistry. 2005, 66, 5–29.
[9]	Shimada, Y.; Yang, Q.; Yokoyama, K.; Goto, H.; Kasahara, Y.; Sekiya, N.; Hikiami, H.; Terasawa, K. Choto-San prevents occurrence of stroke and prolongs life span in stroke-prone spontaneously hypertensive rats. Am. J. Chin. Med. 2003, 31, 79–85.
[10]	Yang, Q.; Goto, H.; Shimada, Y.; Kita, T.; Shibahara, N.; Terasawa, K. Effects of Choto-San on hemorheological factors and vascular function in stroke-prone spontaneously hypertensive rats. Phytomedicine. 2002, 9, 93–98.
[11]	Zhou, J.Y.; Zhou, S.W. Antihypertensive and neuroprotective activities of rhynchophylline: The role of rhynchophylline in neurotransmission and ion channel activity. J. Ethnopharmacol. 2010, 132, 15–27.
[12]	Chou, C.H.; Gong, C.L.; Chao, C.C.; Lin, C.H.; Kwan, C.Y.; Hsieh, C.L.; Leung, Y.M. Rhynchophylline from uncaria rhynchophylla functionally turns delayed rectifiers into A-type K+ channels. J. Nat. Prod. 2009, 72, 830–834.
[13]	Hsieh, C.L.; Ho, T.Y.; Su, S.Y.; Lo, W.Y.; Liu, C.H.; Tang, N.Y. Uncaria rhynchophylla and Rhynchophylline inhibit c-Jun N-terminal kinase phosphorylation and nuclear factor-kappaB activity in kainic acid-treated rats. Am. J. Chin. Med. 2009, 37, 351–360.
[14]	Kang, T.H.; Murakami, Y.; Matsumoto, K.; Takayama, H.; Kitajima, M.; Aimi, N.; Watanabe, H. Rhynchophylline and isorhynchophylline inhibit NMDA receptors expressed in Xenopus oocytes. Eur. J. Pharmacol. 2002, 455, 27–34.
[15]	Liu, Y.X.; Dong, J.H.; Gao, L.; Ma, H.J.; Wu, Y.M.; Zhang, Y.; He, R.R. Inhibition of rhynchophylline on carotid sinus baroreceptor activity in anesthetized rats. Chin. J. Pharmacol. Toxicol. 2009, 23, 161–167.
[16]	Zhang, Q.; Zhao, J.J.; Xu, J.; Feng, F.; Qu, W. Medicinal uses, phytochemistry and pharmacology of the genus Uncaria. J. Ethnopharmacol. 2015, 173, 48–80.
[17]	Zhang, Y.; Sun, J.; Zhu, S.J.; Xu, T.; Lu, J.F.; Han, H.B.; Zhou, C.M.; Yan, J.H. The role of rhynchophylline in alleviating early brain injury following subarachnoid hemorrhage in rats. Brain Res. 2016, 1631, 92–100.
[18]	Shao, H.; Mi, Z.; Ji, W.G.; Zhang, C.H.; Zhang, T.; Ren, S.C.; Zhu, Z.R. Rhynchophylline protects against the amyloid β-induced increase of spontaneous discharges in the hippocampal CA1 region of rats. Neurochem. Res. 2015, 40, 2365–2373.
[19]	Xian, Y.F.; Mao, Q.Q.; Wu, J.C.; Su, Z.R.; Chen, J.N.; Lai, X.P.; Ip, S.P.; Lin, Z.X. Isorhynchophylline treatment improves the amyloid-β-induced cognitive impairment in rats via inhibition of neuronal apoptosis and tau protein hyperphosphorylation. J. Alzheimer’s Dis. 2014, 39, 331–346.
[20]	Yang, Y.; Ji, W.G.; Zhu, Z.R.; Wu, Y.L.; Zhang, Z.Y.; Qu, S.C. Rhynchophylline suppresses soluble Aβ1-42-induced impairment of spatial cognition function via inhibiting excessive activation of extrasynaptic NR2B-containing NMDA receptors. Neuropharmacology. 2018, 135, 100–112.
[21]	Liu, W.; Wang, Z.S.; Zhang, H.; Zhang, X.; Gao, Y.S. Hepatotoxicity of oral rhynchophylla total alkaloids in hypertensive rats. Chin. Pharmacol. Bull. 2014, 30, 883–884.
[22]	Wang, M.; Sun, Q.H.; Liu, W. Experimental study on long-term toxicity of sustained- release dropping pills of Rhynchophylla total alkaloids in rats. Int. J. Tradit. Med. 2014, 36, 905–908.
[23]	Mo, Z.X.; Yang, Q. The effects of rhynchophylla alkaloids on amphetamine-induced behavioral sensitization in mice. Chin. J. Drug Dependence. 2005, 14, 421–424.
[24]	China Food and Drug Administration. Technical Guidance for Single dose toxicity study for pharmaceuticals. [EB/OL]. 2005, 1–8. This article can be found online at http://www.cde.org.cn/zdyz.do?method=largePage&id= b38440b188237c13.
[25]	Ndagijimana, A.; Wang, X.M.; Pan, G.X.; Zhang, F.; Feng, H.; de Olaleye, O. A review on indole alkaloids isolated from Uncaria rhynchophylla and their pharmacological studies. Fitoterapia. 2013, 86, 35–47.
[26]	Shi, J.S.; Yu, J.X.; Chen, X.P.; Xu, R.X. Pharmacological actions of Uncaria alkaloids, Rhynchophylline and Isorhynchophylline. Acta Pharmacol. Sin. 2003, 24, 97–101.